HIGHLIGHTS
Hims AND Hers both hit all-time-high weekly web traffic in the same week (week ending May 17) 🤯
Hims has reclaimed the web traffic lead from Ro, and is now growing faster y/y (+27% vs +19%)
Hers iOS app just posted its best-ever weekly rank in the app store (#11) 🔥
Hers continues to outrank Hims, full stop -- ahead on both the latest week (#11 vs #19) and the 30-day average (#13 vs #21)
Every telehealth app we track climbed this week: Hims, Hers, Ro, and One Medical all improved, and even cellar-dweller LifeMD bounced 30 spots (#195 → #165) though still >100 spots below the rest
Y/y sales now positive 3 of the last 4 weeks. Paired with the strong web traffic + app rankings, it looks like the long-awaited “reacceleration” might finally be here
Hims Meta ads pivoted hard back to !@#$; Hers is leaning into weight loss (now well over half its ads)
“ Hims is a flop” “ Hims is going back to 16” is what everyone was saying a month ago and while it was taking a beating. Happy to see that the company has proved them wrong.
Continuous growth and continuous development since then. Props to all those that didn’t sell and held conviction!
Šiame puslapyje gali būti bendruomenės sukurto turinio, už kurį „Trading 212“ neatsako. Visada atlik savo tyrimą. „Trading 212“ teikia tik vykdymo paslaugą, bet neteikia investavimo konsultacijų ar portfelio valdymo paslaugų.
Prekiauk HIMS ilguoju ir trumpuoju laikotarpiu naudodamas finansinį svertą
Pirk ir parduok Hims & Hers Health Inc +3,31 $ (12,33 %) ir daugiau nei 6 000 akcijų, „Forex“, indeksų ir biržos prekių
Atsisiųsti programėlę
Atidaryti sąskaitą
Prekiauk CFD visose pagrindinėse rinkose
Vertybiniai popieriai
Prekiauk CFD tūkstančiais įvairių akcijų, pvz., „Tesla“, „GameStop“ ir „AMC“ ilgosiomis ir trumposiomis pozicijomis.
Indeksai
Prekiauk CFD svarbiausiais pasaulio indeksais, tokiais kaip USA 500, USA 30 ir UK 100.
Biržos prekės
CFD taurųjų metalų, naftos ir nišinių žemės ūkio produktų, pvz., medienos ir galvijų.
„Forex“
CFD daugiau nei 180 porų visą parą 5 dienas per savaitę.
Visi pateikti statistiniai duomenys yra globalūs. Klientų skaičius atspindi finansuotas sąskaitas.
Puiku
Įvertinta 4,6/5, remiantis 94 874 atsiliepimais apie
Trustpilot
Įvertinta 4,6/5, remiantis 94 874 atsiliepimais apie
Trustpilot
Pakviestas
Great app
Great app, great brand. Easy and user friendly. Low to non existent commissions
Pakviestas
Excellent app make's it so easy to…
Excellent app make's it so easy to monitor my investments.
Pakviestas
It's a great app
It's a great app
Easy to use
Pakviestas
Stress free savings
Simple, effective and stress free savings. Really useable app making it easy to track your savings progress. Couldn’t recommend highly enough
Pakviestas
Easy to invest
Easy to invest, and set up recurring payments and auto investments. App is very user friendly.
Pakviestas
Easy to navigate app for new investors
Easy to navigate app for new investors
Pakviestas
Efficient and secure service
On recent transaction T212 Team were fast and efficient with due regard to security.
Pakviestas
The best app to start trading
This app gives you good guidance as well as a feed. The feed can be really helpful when trying to chose what you want to invest in as it’s current real time info. It also has a section for practicing trading. Possibly one of the best things an app like this could do. If u want to start trading I would definitely recommend this app. Perfect for begnners
Pakviestas
Best of 4 brokers I use
Low costs, easy to use, Pie possibility is great, interest on your balance.
Pakviestas
Tried a few other trading apps over…
Tried a few other trading apps over last 3 years. 212 seems the best and offers optimum range of stocks, etfs etc
Pakviestas
Great App
The app is really easy to use and makes deposits and withdrawals extremely quickly, it is also very secure, I really like this app
Pakviestas
Nothing but positive experience
Easy to set up, use and understand, great customer service!
Pakviestas
Easy to use.
Easy of use. No delays if withdrawals required
Pakviestas
Great app to use
Great app to use. The interface is so beginner friendly
Pakviestas
Ka-Ching !
A brilliant investment platform, paying competitive interest rates in savings.
Pakviestas
Free trading
Free trading, cashback, lots of investing options, friendly app look.
Pakviestas
Easy to use and competitive fees
So easy to use and competitive fees. I moved from ii to here for that reason alone
Pakviestas
Easy to invest and easy to track…
Easy to invest and easy to track interest via the app with a great interest rate too.
Pakviestas
Great platform
I love this trading platform and it’s features, I have had a great experience with them so far.
Pakviestas
Great to watch your investment grow…
Great to watch your investment grow each day fab app
Pateikiami keli teigiami mūsų klientų atsiliepimai
Mūsų apdovanojimai
Dažniausiai užduodami klausimai
Kokia yra Hims & Hers Health (HIMS) akcijos kaina?
Dabartinė Hims & Hers Health (HIMS) kaina yra 30,15 $.
Koks yra HIMS52 savaičių maksimumas?
52 savaičių maksimumas HIMS yra 70,39 $.
Koks yra HIMS 52 savaičių žemiausias lygis?
52 savaičių žemiausias HIMS kursas yra 13,72 $.
Koks yra HIMS savaitės rezultatas?
Per pastarąją savaitę HIMS kaina pasikeitė 15,03 %.
Koks yra HIMS mėnesio našumas?
Per pastarąjį mėnesį HIMS kaina pasikeitė 20,41 %.
Koks yra HIMS 3 mėnesių rezultatas?
Per pastaruosius tris mėnesius HIMS kaina pasikeitė 26,2 %.
Koks yra HIMS 6 mėnesių rezultatas?
Per pastaruosius šešis mėnesius HIMS kaina pasikeitė −19 %.
Koks yra HIMSmetinis našumas?
Per pastaruosius metus HIMS kaina pasikeitė −47,27 %.